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Abstract
Background: Attention Deficit Hyperactivity Disorder (ADHD) is a costly and prevalent disorder in the U.S.,
especially among youth. However, significant disparities in diagnosis and treatment appear to be predicted by the
race and insurance status of patients.
Methods: This study employed a web-based factorial survey with four ADHD cases derived from an ADHD clinic,
two diagnosed with ADHD in actual evaluation, and two not. Randomized measures included race and insurance
status of the patients. Participants N = (187) included clinician members of regional and national practice-based
research networks and the U.S. clinical membership of the Society of Teachers of Family Medicine. The main
outcomes were decisions to 1) diagnose and 2) treat the cases, based upon the information presented, analyzed
via binary logistic regression of the randomized factors and case indicators on diagnosis and treatment.
Results: ADHD-positive cases were 8 times more likely to be diagnosed and 12 times more likely to be treated,
and the male ADHD positive case was more likely to be diagnosed and treated than the female ADHD positive
case. Uninsured cases were significantly more likely to be treated overall, but male cases that were uninsured were
about half as likely to be diagnosed and treated with ADHD. Additionally, African-American race appears to
increase the likelihood of medicinal treatment for ADHD and being both African-American and uninsured appears
to cut the odds of medicinal treatment in half, but not significantly.
Conclusions: Family physicians were competent at discerning between near-threshold ADHD-negative and ADHD
positive cases. However, insurance status and race, as well as gender, appear to affect the likelihood of diagnosis
and treatment for ADHD in Family Medicine settings.
Background
Attention Deficit Hyperactivity Disorder (ADHD) is a
wide-spread and behavioral condition in the U.S. It
affects roughly 7% to 9% of the U.S. population aged 4-
17 years [1-3]. By one estimate, ADHD costs the U.S.
economy between $36 billion and $52 billion per year
(in 2005 U.S. dollars), or roughly $12,000 to $17,000 per
affected individual, per year [4,5]. ADHD is also the
source of significant morbidity, including social, emo-
tional, economic, and even secondary physical suffering
in affected children. It is associated with an increased
propensity for lowered self-esteem, stigmatization,
school failure, poor socialization, tobacco use, drug and
alcohol abuse, traffic accidents and occupational issues
that persist into adulthood [6-10]. However, only slightly
more than half of those diagnosed with ADHD are actu-
ally under treatment for it at any given time [2,3].
The data are unclear on the precise amount of ADHD
diagnosis and treatment occurring in primary care set-
tings, but it is fair to say that it is substantial. In fact, as
much as 65% - 85% of initial ADHD diagnosis and treat-
ment occurs in primary care settings (e.g. Pediatric or
Family Medicine practices) [11,12]. Once a child has
been determined to meet the basic criteria for ADHD,
the next step recommended by a number of authorita-
tive sources is referral to an ADHD specialist, such as a
mental health professional, ADHD subspecialty clinic, or
Neurodevelopmental Pediatrician [13,14]. However, in
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other accessibility issues at subspecialty clinics, and
insurance issues often conspire to leave diagnosis and
treatment in the hands of the primary care physician
[12,15,16].
Both the American Academy of Child and Adolescent
Psychiatry and the American Academy of Pediatrics
have issued formal guidelines for the diagnosis and
treatment of ADHD [17-19]. However, these guidelines
have been difficult to implement, [17,20-22] and a num-
ber of voices have stressed the need to improve quality
of care for children presenting with ADHD symptoms
in primary care settings [16]. Implementation, accep-
tance, and even knowledge of the existence of ADHD
guidelines are all highly variable within and across medi-
cal specialties and disciplines [23-28]. Possibly owing to
the fact that the present primary care guidelines for
ADHD management originated within the Pediatric
medical specialty, several of these studies indicate a par-
ticular lack of familiarity with the guidelines, and with
comfort levels in diagnosing and treating ADHD, in
Family Physicians [11,23,27,28]. For example, a study of
primary care physicians in Minnesota found that 54% of
Family Physicians were altogether unaware of the AAP
guidelines introduced in 2004 [29]. Similarly, Rushton
and colleagues surveyed 1374 primary care physicians,
and found that 91.5% of Pediatricians were familiar with
AAP guidelines, while only 59.8% of Family Physicians
were similarly familiar [27]. Even more pronouncedly,
Lanham and colleagues surveyed 17 civilian & 17 mili-
tary Family Medicine residency programs, and found
that only 22% were familiar AAP guidelines, and only
12.9% reported that they regularly screen for ADHD.
Additionally, a majority of respondents across both pro-
gram types used inappropriate methods to arrive at a
diagnosis; 70% of Family Physicians surveyed reported
use of a child’s behavior in the office in the diagnostic
process, and 53% use response to stimulants to diagnose
[23].
In addition to apparent variability in clinical practices,
a wide array of social factors appear to cause disparities
in diagnosis and treatment for ADHD, especially
between races, genders, and socio-economic indicators
[30-32]. Studies based upon parental reports suggest
higher prevalence rates in whites [1], and a study by
Froelich et al, comparing prior diagnosis of ADHD to
assessment via a standardized instrument in a nationally
representative cross-sectional survey, determined that
poor children were more likely to meet ADHD criteria
(adjusted odds ratio [AOR], 2.3; 95% confidence interval
[CI], 1.4-3.9), that 47.9% of children who met criteria
actually had a prior diagnosis of ADHD, and that only
32.0% were consistently treated with appropriate medi-
cations in the year prior to the survey. The same study
found that ADHD tends to be missed in girls, relative to
b o y s ,( A O R ,0 . 3 ;9 5 %C I ,0 . 1 - 0 . 8 ) ,a n dw e a l t h yc h i l d r e n
had a greater likelihood of receiving regular medication
than the poorest of the sample (AOR, 3.4; 95% CI, 1.3-
9.1). As a corollary to the overarching issue of poverty,
other studies looking explicitly at patient insurance sta-
tus have distinctly identified it as having a significant
effect upon who is diagnosed with and treated for
ADHD [3,33].
ADHD diagnosis and treatment rates clearly fall along
several socio-demographic lines. Gender, geography,
wealth, and ethnicity all seem to play roles, in addition
to race and insurance status [1,2,30,34-38].
Given the apparent socioeconomic disparities that
have been observed in ADHD diagnosis and treatment,
as well as the particular issues that appear to be present
when cases of suspected ADHD present in primary care
offices, a vignette-based factorial web survey experiment
designed to test the effects of two social factors on the
likelihood of diagnosis and treatment of Attention Defi-
cit Hyperactivity Disorder (ADHD) in children, as
applied by primary care providers (PCPs), and focused
upon Family Physicians (FPs), was conducted in a con-
venience sample of PCPs. This study has focused upon
race and insurance status in an isolated fashion, as these
two items may co-vary [33]. The specific objectives of
this endeavor are to test the effect of patient race (black
vs. white) and insurance status (insured vs. uninsured)
upon likelihood of diagnosis with ADHD by primary
care providers (PCPs), particularly Family Physicians
(FPs). The central research question addressed by this
study asks whether randomly varying the race and insur-
ance status in marginal ADHD cases has any effect upon
the likelihood of ADHD diagnosis and treatment.
Methods
Factorial Survey Design & Procedures
A more complete description of the methods employed
in this study is available elsewhere [39]. However, it is
useful to offer an overview of these methods here. The
current project utilized four case studies, or vignettes,
each consisting of three paragraphs of information
about a particular patient. The vignettes were included
in a web-based survey of primary care physicians, with
each respondent seeing each of the four vignettes which
they then “diagnosed” and “treated” by selecting from a
set of choices following each vignette. The vignettes in
each case were held constant from respondent to
respondent, with the exception of the first line of each.
This first line was a generic statement following the
form:
“An X-year old (White/African-American), (privately
insured/uninsured) child is in your office for a visit.”
Randomization of race and insurance status was
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employed by Grant Systems, Inc., and occurred as the
respondent entered each vignette page, resulting in 256
different possible combinations of race/insurance altered
vignettes. Following the four vignettes, respondents then
answered 20 questions about their training, specializa-
tion, practice, and demographic traits, attitude towards
behavioral diagnoses in children, and comfort treating
childhood behavioral cases. The four cases utilized in
this study are presented in Additional File 1.
This study was granted an exemption from review by
the Institutional Review Boards of Syracuse University
and SUNY Upstate Medical University. Nevertheless, all
had to pass through an informed-consent page before
participating in the survey. Respondents who chose to
continue next went to a page containing basic instruc-
tions and a randomly selected version of the first vign-
ette (i.e. White/Privately Insured, White/Uninsured,
African-American/Privately Insured, African-American/
Uninsured). At page bottom, immediately following the
vignette, were three questions, asking the respondent to
select a) a diagnosis from a set of four (No Diagnosis,
Oppositional Defiant Disorder, ADHD, Bipolar Disor-
der) and b) a treatment option, from a set of six (No tx/
monitoring, psychotherapy only, stimulant, combined
medication and psychotherapy, mood stabilizer, anti-
psychotic). Once finished with the first vignette and set
of questions, respondents were taken to randomized
versions of Vignettes 2 through 4, with the same set of
questions and options after each.
Case Development & Validation
The vignettes utilized in this experiment were derived
from four cases seen at a local ADHD specialty clinic,
with two of the cases nominally meeting criteria for
ADHD upon formal evaluation and two cases of sus-
pected ADHD that ultimately did not meet the criteria
for diagnosis, upon evaluation. The four cases were
intentionally distributed as two sub-threshold cases, 1
male, 1 female, and two “true” A D H Dc a s e s ,a g a i n ,1
male, 1 female. These cases where selected by two psy-
chologists specializing in ADHD diagnosis, who sent
case information on anonymous abstracting forms.
Information from the abstracting forms was utilized to
create a 3-paragraph, narrative vignette describing each
case. All four of the cases were derived from actual
patients who had been psychometrically tested for the
presence of ADHD after referral from an external
source. Marginal, as opposed to “clear-cut,” cases were
used in order to isolate the effects of patient race and
insurance status from large variations in presentation of
symptoms from case to case.
Some confidence in the content validity of the vign-
ettes employed in this study may be taken from the fact
that they were drawn from the facts of actual cases.
Nevertheless, additional steps were taken to assure that
the vignettes performed reliably when employed within
the instrument, i.e. that they produced reasonably pre-
dictable diagnostic recommendations when read by mul-
tiple clinicians from a variety of relevant specialties.
Additionally, the vignettes were modified iteratively until
they were both reliable in eliciting appropriate responses
from a beta panel of diagnosticians, as well as direction-
ally accurate (i.e. until each vignette elicited consistent
diagnoses that matched that of the psychometrically
evaluated actual cases they were derived from).
Following the abstraction and vignette generation,
each of the four vignettes were submitted to a panel of
18 primary care physicians and mental health experts
blinded to the “true” diagnosis in each case in a draft
version of the web-based instrument. Each rater selected
a diagnosis and treatment from a set of options for each
vignette and was asked to provide summary comments
about what affected their decision in a text box follow-
ing each vignette.
The alpha panel test was conducted in May and June
of 2008. Results were formally analyzed by rotating the
matrix of responses so that each vignette represented a
row and each “response” was the diagnosis assigned by
each of the 18 respondents. Cronbach’s Alpha split-half
correlation was calculated for the matrix. Additionally,
the comments entered into the text boxes were analyzed
for appropriate content, e.g. that respondents were not
openly declaring social biases or blatantly incorrect
knowledge while diagnosing each case. Finally, panel
respondents confidentially made recommendations on
improving each vignette either in direct conversation, by
e-mail, or via a secondary web interface. A second goal
of the alpha test was to assess the pure functionality of
the instrument and web interface, including the speed,
data collection and delivery mechanisms, randomization
engine, password functioning, etc.
The instrument, vignettes, and collection interface
were modified based upon initial data analyses, content
analysis of remarks included in question #3 after each
vignette, direct verbal feedback, and observation of the
manner in which the instrument and interface func-
tioned. The second iteration of the survey instrument
was successfully beta-tested in August and September,
2008, and produced a reasonable reliability score
(Crohnbach’s a = .866).
Sample Size and Recruitment
A pre-study power analysis, performed using G*3
Power 3.0.5 [40], determined that a total N of 129
cases diagnosed would be necessary to detect a moder-
ate effect using four independent variables, with a at
.05 (CI = 95%). A need for an N of 129 cases translated
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cases each.
Several strategies were utilized to obtain and surpass
the target N. First, distribution through regional and
national Practice-Based Research Networks (PBRNs)
insured that physicians interested in participating in
research studies were invited to participate; such interest
is an assumed pre-requisite for members of PBRNs.
Additionally, going to both regional and national
PBRNs, as well as approaching the non-PBRN general
membership of professional societies such as the Society
of Teachers of Family Medicine, opened the recruitment
pool up to literally thousands of individuals. As an
incentive for participation, invitees were offered a $25
stipend plus the opportunity to earn free Continuing
Medical Education in the future (currently under
development).
Data Analysis
Analyses of the dependent variables were conducted in
several steps. Before proceeding to regression analyses,
c
2 statistics were computed to determine whether there
were any significant differences in the distribution of
respondent characteristics between vignettes randomized
as White/Insured, White/Uninsured, African-American/
Insured, or African-American/Uninsured (the four pos-
sible factorial combinations). Absence of significant dif-
ferences in respondent characteristics across the four
factorial combinations was accepted as evidence that the
randomization procedure was effective, and hence it was
unnecessary to control for any non-significant respon-
dent characteristics.
The data were then analyzed by creating binary diag-
nostic and treatment outcome variables. For diagnostic
outcomes, cases given “no diagnosis” or Oppositional
Defiant Disorder (ODD) were labelled 0 and cases given
ADHD or Bipolar (BP) were labelled 1. ODD and BP
were so infrequently selected that removing them from
the analysis made essentially no statistical difference.
Similarly, treatment selections were grouped into those
that would result in a medicinal intervention (1, where
stimulant, combined therapy, mood stabilizer, or anti-
psychotic were selected), andt h o s et h a tw o u l dn o t( 0 ,
where No treatment or psychotherapy only were
selected). Binary logistic regressions were calculated for
each dependent variable (Diagnosis & Treatment) using
the responses from the four cases, modelled against
race, insurance status, case gender, ADHD status of the
case, and interaction effects.
Results
Sample Characteristics
Collection of responses for the full data set (N = 187)
occurred primarily from September through December,
2008, with a small number of late respondents entering
t h es u r v e yi nJ a n u a r ya n de arly February, 2009. All
respondents completed the survey. Respondents came
from 35 states, with the largest number coming from
New York (roughly 30%), followed by Georgia (roughly
9%) and Pennsylvania (roughly 7%). The sample was
heavily skewed towards White respondents (87.7%
White) and was evenly split between male and female
respondents (50.8% male, 49.2% female). Physicians edu-
cated in the United States were also over-represented at
94.6%, compared to the population of total U.S. physi-
cians (74.5%) [41] and to Family Physicians (83.7%) [42].
1 7 2o f1 8 7r e s p o n d e n t si d e n t i f i e dt h e m s e l v e sa sp r a c -
ticing within the Family Medicine specialty, with the
rest identifying themselves as Pediatricians. Respondents
were mostly MD’s (86.6%), followed by DO’s( 1 1 . 2 % ) ,
with one physician respondent holding a non-U.S. medi-
cal credential (M.B.B.S). Three mid-levels (Nurse Practi-
tioners or Physician Assistants) also responded. Average
time in practice was approximately 16 years and was
fairly evenly distributed across a range of 1 to 36 years
(S.D. = 9.71 years). Most respondents saw at least some
poor and/or non-white patients in their practices, with
39% indicating their patient panel consisted mostly of
poor/non-white or mostly poor/white patients. An addi-
tional 17.1% selected an “Other” option to describe their
patient population but the majority of these respondents
textually indicated a diverse patient population that
included poor patients, non-white patients, or both.
Almost two thirds of respondents indicated either
Urban, Suburban, or mixed Urban/Suburban practice
settings (64.1%). The full distribution of sample charac-
teristics is displayed in Tables 1, 2 and 3.
Results for Diagnostic & Treatment Decisions
Several exploratory analyses that incorporated respon-
dent characteristics as covariates, including type of pro-
fessional credential, level of training, normal patient mix
(peds/adult and race/class), and practice setting (along a
rural-urban scale) did not reveal any of these covariates
to be statistically significant. Of possible note, years of
training appeared to approach significance, and so num-
ber of years in practice was included in the final binary
logistic regression models.
Neither race nor insurance status appears to be an
independent predictor of diagnosis in the clustered,
four-case model presented in Table 4. The most pro-
nounced effect was that of “true” ADHD status of the
vignette: the ADHD-positive cases both produced rela-
tively large effect sizes and low p-values when regressed
against diagnosis, indicating that ADHD status was a
primary endogenous predictor of diagnosis, with the
male ADHD-positive case almost three times as likely
to be diagnosed (Case 3 [Male, Positive]: OR = 8.006,
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.001). Insurance status, however, appears to interact
with gender to influence diagnosis in this model. Male
vignettes randomized as uninsured cut the odds of diag-
nosis in half, although this effect did not achieve statisti-
cal significance (O.R. = .546, p = .062).
The effects of race and insurance status upon treat-
ment decisions were more direct. Cases randomized as
African-American were slightly more likely to be medi-
cated, an effect which approached but did not reach sig-
nificance (O.R. = 1.514, p = .072), and being uninsured
significantly increased the likelihood of being medicated
(O.R. = 1.837, p = .021). Cases randomized as both Afri-
can-American and uninsured were less likely to be
medicated, although this effect was not significant. As
with diagnostic decisions, treatment decisions were
highly predicted by true ADHD status of the cases.
Furthermore, a gender contrast once again appears
between the ADHD-positive cases, with Case 3 (the
male case) being over 11 times more likely to be medi-
cated or treated with combined medication and psy-
chotherapy (O.R. = 11.840, p < .001) than the male,
ADHD-negative reference case, while Case 4 (the female
case) was only about 3 times as likely than the reference
case to be medicated (O.R. = 2.950, p < .001).
Discussion
This study was a focused exploration into how primary
care physicians, and specifically Family Physicians,
approach the diagnosis and treatment of ADHD in chil-
dren. It was specifically looking at how social factors
may influence an ostensibly objective clinical process.
Given this central focus, it is important to begin this
discussion by clearly stating that the respondents, as a
whole, were effective at correctly discriminating between
ADHD and non-ADHD cases in their diagnostic
Table 1 Distribution of Respondents across U.S. States
State Frequency Percent
New York 55 29.41%
Georgia 16 8.56%
Pennsylvania 13 6.95%
California 9 4.81%
Michigan 9 4.81%
Illinois 8 4.28%
Missouri 8 4.28%
Virginia 8 4.28%
New Jersey 7 3.74%
North Carolina 6 3.21%
Texas 5 2.67%
Indiana 4 2.14%
South Carolina 4 2.14%
Wisconsin 4 2.14%
Arizona 3 1.60%
Massachusetts 3 1.60%
Minnesota 3 1.60%
Maine 2 1.07%
Mississippi 2 1.07%
Ohio 2 1.07%
Wyoming 2 1.07%
Alabama 1 0.53%
Alaska 1 0.53%
Colorado 1 0.53%
Delaware 1 0.53%
Hawaii 1 0.53%
Louisiana 1 0.53%
Maryland 1 0.53%
Montana 1 0.53%
Nevada 1 0.53%
New Mexico 1 0.53%
Oklahoma 1 0.53%
Oregon 1 0.53%
Tennessee 1 0.53%
Washington 1 0.53%
Total 187 100.0
Table 2 Demographic Characteristics of Respondents
Number Percent Population
Gender
Male 95 50.8% 76.0%^/64.9%*
Female 92 49.2% 24%^/35.1%*
187 100%
Native U.S
U.S 170 91% 81%^
Non-U.S 17 9% 19%^
187 100%
Race
White 164 88% 44-86%’
Asian/Pacific Islander 95 % 8 % ’
Black 42 % 2 % ’
Other 10 5% ~2%’
187 100%
Hispanic/Latino
Non-Hispanic 179 95.7% 98%’
Hispanic/Latino 8 4.3% 3%’
187 100%
Medical School
Attended U.S. Medical School 177 94.6% 74.5%^/83.7%*
Attended non-U.S. Medical School 10 5.4% 25.5%^/16.3%*
187 100%
^ Total U.S. Physician Population, as of 2000 (American Medical Association.)
http://www.ama-assn.org/ama1/pub/upload/images/373/internettable.gif
* Total membership of American Association of Family Physicians as of 2008
(American Academy of Family Physicians.) http://www.aafp.org/online/en/
home/aboutus/specialty/facts/2.html
’Distribution of Nonfederal Physicians by Race, 2008, Kaiser Family Foundation.
http://www.statehealthfacts.org/comparetable.jsp?ind=431&cat=8
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likely to be diagnosed and treated in all models con-
structed with these data. Furthermore, the cases that
study participants were reading and responding to were
intentionally marginal; all displayed at least some symp-
toms consistent with an ADHD diagnosis. Also, the par-
t i c i p a n t si nt h es t u d yd i dn o th a v et h eo p p o r t u n i t yt o
utilize follow-up questions, formal diagnostic processes
(such as real-time interviews with parents, or evaluation
via Connors instruments, etc.) or consults, or otherwise
acquire additional case information, as they would in an
actual clinical setting. Despite the uncertainty and unfa-
miliarity with ADHD guidelines identified by other stu-
dies in primary care and FP populations
[11,23,24,29,43], the respondents to this survey were, as
a group, competent at handling ADHD cases. However,
insurance status and race appear to play a role in how
ADHD is diagnosed and, more pronouncedly, treated, in
primary care.
Effects of Insurance Status
Insurance status appears to play a somewhat compli-
cated role in determining which children are diagnosed
with and treated for ADHD in a primary care setting.
Being uninsured lowered the odds of diagnosis in male
cases, an effect that comports with trends repeatedly
observed elsewhere [33]. This diagnosis-suppressing
effect of being identified as uninsured was not observed
in the female-identified cases. The question requires
further study, however. What is clear from this study is
that, at least in male cases, being uninsured reduced the
odds of diagnosis.
The picture is somewhat different for treatment deci-
sions. Both African-American race and uninsured status
individually increase the odds of medicinal or combined
medicinal/psychotherapeutic treatment, with the
Table 3 Practice Characteristics of Respondents
Number Percent
Credential
MD 162 86.6%
DO 21 11.2%
MBBS 1 0.5%
Mid-Level 3 1.6%
187 100%
Specialty or Area of Practice
Family Medicine 172 92.0%
Pediatrics 15 8.0%
187 100%
Years in Practice
Range: 1-36 years; Weighted Avg: 16.09 years (SD: 9.71)
Patient Population
Mostly poor, non-white 52 27.8%
Mostly poor, white 21 11.2%
Middle class, mixed race/ethnicities 57 30.5%
Middle class, mostly white 24 12.8%
Middle class, mostly white, 1 0.5%
Other (Most indicated low SES) 32 17.1%
187 100%
Practice Setting
Rural 22 11.8%
Mixed Rural/Suburban 28 15.0%
Mixed Suburban/Urban 24 12.8%
Mixed Rural/Suburban/Urban 12 6.4%
Mixed Rural/Urban 5 2.7%
Suburban 32 17.1%
Urban 64 34.2%
187 100%
Table 4 Binary Logistic Regression results of the four-case model.
Variable Diagnosis
0 = no Dx, or ODD
1 = ADHD or BP
Odds Ratio (p), CI
Treatment
0 = No Tx, or Psychotherapy Only
1 = Medicinal or Combined Tx
Odds Ratio (p), CI
African-American (AA) 1.343 (0.191), 0.863 - 2.092 1.514 (0.072)^, 0.963 - 2.380
Uninsured 1.176 (0.529), 0.710 - 1.947 1.837 (0.021)*, 1.095 - 3.081
AA × Uninsured 0.700(0.269), 0.372 - 1.318 0.582 (0.110)^, 0.303 - 1.117
Case 2 1.398 (0.197), 0.841 - 2.326 0.876 (0.595), 0.519 - 1.478
Case 3 8.006 (<.001)**, 4.936 - 12.987 11.840 (<.001)**, 7.090 - 19.772
Case 4 2.967 (<.001)**, 1.751 - 5.028 2.950 (<.001)**, 1.734 - 5.017
Male(1) × Uninsured(1) 0.546 (0.062)^, 0.289 - 1.030 0.409 (0.007)**, 0.212 - 0.786
Years in Practice 0.985 (0.060)^, 0.969 - 1.001 0.986 (0.106), .970 - 1.003
Constant 0.832 (0.061) 0.651 (0.102)
* Significant at the .05 level.
**Significant at the < .01 level
^Approaching significance
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approaching significance. However, when interacted, the
two variables together serve to cut the odds of treatment
in half, although this interaction effect was not signifi-
cant in this relatively small study. Also observed was a
very significant interaction between male gender and
being uninsured, with this combination of factors redu-
cing the odds of treatment by half, in line with the
observed effect on diagnosis. It would be speculative to
suggest explanations for this effect at this point, but this
finding underscores the need for further study of gender
and ADHD. The addition of both gender-null and insur-
ance-null cells in a future follow-up study would help
resolve this question.
Fundamentally, what may be drawn from the current
study about insurance status is that patients presenting
as uninsured are generally less likely to be diagnosed
with and treated for ADHD. This effect is apparently
moderated by both race and gender. These latter inter-
actions require further examination, however.
Effects of Race
Race was a non-factor in predicting diagnostic outcomes
in this study. However, it appears to play a more impor-
tant role in determining physician decisions about treat-
ment, as well as in moderating the effect of insurance
status. As noted above, the positive effect observed in
the female ADHD positive case when presented as unin-
sured was completely and significantly reversed when
the case was both African-American and uninsured.
When grouped by ADHD status, the ADHD-positive
cases were more than twice as likely to be diagnosed
when identified as African-American, but only about a
third as likely to be diagnosed when identified as both
African-American and uninsured. This indicates that
some but not all of this effect may be due to its pre-
sence in Case 4. While neither race alone nor the race ×
insurance interaction were statistically significant in the
four-case model, the trends remained consistent - Afri-
can-American race alone increased the odds of treat-
ment, but the interaction between race and insurance
status decreased these odds. The fundamental role of
race appears to moderate the effects of insurance status.
Weaknesses of the Study
There were several central challenges in the design of
this study. First was the need to generate an adequate
sample size. The study population consisted of busy,
over-surveyed primary care physicians. Physician surveys
have notoriously low rates of response, and the methods
that prove most effective - monetary incentives and
mixed web/paper survey distribution - are generally
costly and labor-intensive [44,45]. Given limited
resources, providing both an adequate monetary
incentive and pursuing a mail-based paper alternative to
a web-based survey was impractical. Additionally, the
web survey was constructed to randomize both race and
insurance status of the vignettes as respondents entered
the instrument; the use of a paper survey would have
required pre-randomized blocks of invitees to receive
fixed paper versions of the survey. While this is not the-
oretically problematic, the low response rates typically
seen in physician surveys raised the danger of an imbal-
anced response rate between blocks. While such an
eventuality is correctable with continued collection
focused upon the under-represented blocks, such a
strategy would have demanded more resources than
were available. For these practical reasons, this study
relied upon web-based collection alone.
An obvious challenge for this study was the fact that
the respondents were reacting to purely textual vign-
ettes, as opposed to live, actual or standardized patients.
Despite this weakness, vignette-based studies have a
long history of effectively demonstrating the effects of
discrete factors while holding a body of information
constant. For example, Lutfey, McKinley and colleagues
have recently utilized vignettes to examine both the cog-
nitive pre-dispositions of physicians as they gather
patient information, as well as the resulting decisions of
such cognitive processes. For example, Lutfey and col-
leagues recently used a vignette based approach to do
precisely this for clinical decision making scenarios
involving Coronary Heart Disease and Depression
[46-49]. Another related challenge in pursuing clinical
vignette research is the basic need to create vignettes
and response options that are realistic enough to be
taken seriously, but not so complex as to hinder efficient
and interpretable analysis. In the current context, physi-
cians are not faced with a simple choice of deciding
“ADHD or not,” in binary fashion, when evaluating a
child with behavioral symptoms. Offering a diagnostic
choice between ADHD or no diagnosis at all would
have been unrealistic, and would furthermore have par-
tially revealed the study design to respondents. There-
fore, reasonable differential diagnoses were offered along
with the choice between selecting ADHD or no diagno-
sis at all.
Additionally, the physician sample obtained for this
study was clearly not representative of the U.S. physician
population as a whole. Recruitment relied in some cases
upon pass-along invitations by network directors, as
well as upon snow-ball techniques from colleague to
colleague. An accurate response rate is therefore difficult
to measure. It is safe to say, however, that the response
rate fell below 10%. This study therefore relied upon a
sample of convenience. It furthermore relied upon those
who were willing and able to open and respond to an e-
mail invitation and web-based survey instrument.
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structure of the data matrix that may be viewed as study
weaknesses as well. Given the extreme difficulty in
recruiting large samples of physicians to complete sur-
veys, the use of four vignettes per respondent allowed
for the potential to quadruple the power of the study,
and this proved crucial. However, the use of four cases
per respondent introduced the issue of panel-oriented
autocorrelation in the variance-covariance matrix. This
proved to be of only moderate concern, and was gener-
ally addressable by incorporating between-subject and
between-case variables into the analytic models, obviat-
ing the need for more advanced statistical measures
which dilute the efficiency or interpretability of results
to some extent. Some issues could not, however, be
addressed. For example, the ability to analyze the inter-
action between clinician and patient race was severely
limited by multicollinearity, and clinician/patient gender
interactions were severely penalized by the data struc-
ture as well. Both had to be eliminated altogether. Addi-
tionally, it must be noted that the truly experimental
phase of this study is limited to the analyses of the indi-
vidual cases, which may have been underpowered.
Although useful, the two-case and four-case analyses
combined multiple vignettes, thus eliminating the ability
to control for all variation other than race and insurance
status. These analytic phases must therefore be consid-
ered quasi-experimental.
Conclusions
Presently, reform of the U.S. healthcare system is under
robust and serious discussion. At the core of this discus-
sion is a presidential plan to reduce health disparities,
drive down healthcare costs, increase usage of electronic
medical records, and universalize health insurance,
improve coordination of care, and enhance quality of
care [50]. In such an expansive conversation, this study
serves to illustrate that disparities in healthcare must
remain central, and that the root causes require further
exploration. It is no secret that disparities in health and
healthcare exist, nor that differentiated patient charac-
teristics such as race, insurance status, and others are
intimately connected to such disparities, for a variety of
conditions and settings [51-54]. This study serves to
illustrate one manner of how patient insurance status
a n dr a c em a yl e a dt oad i s p a r i t yi nt h ec a r ep a t i e n t s
receive across groups, in the context of one condition.
Several recommendations along these lines may be
made based upon the current study. First, further devel-
opment and evolution of guidelines for the diagnosis
and treatment of ADHD [16,22,27,55,56] need to incor-
porate a) explicit statements regarding an emphasis on
impairment and, to a lesser extent, upon symptom pre-
sence, and b) explicit statements directing physicians to
avoid relying upon socioeconomic or racial characteris-
tics when conducting evaluations. Future studies may
implicate the need to include gender in this list. Alter-
natively, the next iteration of clinical guidelines may be
adopted to more closely resemble the usual case presen-
tations of females and non-white patients. In particular,
some have criticized current and previous clinical guide-
lines for ADHD as being more applicable to boys than
girls, and developing guidelines that are gender-sensitive
may be a crucial next step [57]. As noted previously,
there are noted gaps in ADHD guideline familiarity
within the community of FP’s. Guidelines that can rea-
listically be applied must not only be developed [15,26];
it is important to proactively disseminate such informa-
tion to all who would make use of it.
Additionally, as noted by Starfield [58], the process of
referral must be streamlined. In this case, the specific
referral path under consideration is from primary care
to mental health specialist. While the primary care phy-
sicians who participated in this study were generally
effective at correctly identifying and treating ADHD,
easier access to specialist services may serve to amelio-
rate disparities by facilitating more extensive diagnostic
evaluations, especially in ambiguous cases. A lack of
referral options has been noted as a barrier to care in a
number of studies of the ADHD diagnostic process in
the U.S [16,59].
Given both the results and the weaknesses described
above, the first and foremostr e c o m m e n d a t i o ni st h a t
additional research is needed. Specifically, an expansion
of the vignette-based approach is in order, which should
have the following aims:
1. Incorporation of gender as a factorial variable,
along with race and insurance status
2. Increase in study N
3. Increase inclusion of Pediatricians
4. Increase inclusion of non-Academics.
Additionally, follow-up studies incorporating data
from actual practice should be conducted, to triangulate
and corroborate the findings presented here. Ultimately,
a multi-method approach employed across convergent
studies will be necessary and is warranted. Finally, utili-
zation of the methods employed in this study to exam-
ine the effects of patient characteristics in other medical
and mental health specialties, as well as in educational
professionals, is warranted.
What this study has examined is but one very particu-
lar context where disparities in the provision of health-
care, and specifically the diagnosis and treatment of
ADHD, may be generated. Clearly, there is much more
work to be done in examining other sources of disparity.
However, what may be determined from the results
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Page 8 of 10presented here is that insurance status clearly impacts
the provision of ADHD services in primary care. Ameli-
orating health insurance disparities, and improving
guidelines to enhance their applicability to uninsured,
referral-deprived, and non-white/non-male patients are
one step toward accomplishing an egalitarian distribu-
tion of services for ADHD in children.
Additional file 1: ADHD Vignettes used in this study. Vignettes 1 & 2
were designed to be sub-clinical, non-ADHD, and were derived from true
cases where ADHD was ruled out upon a full evaluation of the patient.
Vignettes 3 & 4 were derived from cases where a full evaluation led to a
diagnosis of ADHD.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2296-11-
11-S1.DOC]
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